Edouard Sage

Edouard Sage

Auto-generated profile, based on publicly available information

Edouard Sage

Department of Thoracic Surgery and Lung Transplantation Foch Hospital Suresnes France

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
MFMarie-Louise Felten
Marie-Louise Felten
MMMireille Michel-Cherqui
Mireille Michel-Cherqui
ESEdouard Sage
Edouard Sage
MFMarc Fischler
Marc Fischler

12 February 2008 in Respiratory Research
Verified
Journal Article
Open access
PDF file
ESEdouard Sage
Edouard Sage
OMOlaf Mercier
Olaf Mercier
FEFrederic Van Den Eyden
Frederic Van Den Eyden
MPMarc de Perrot
Marc de Perrot
ABAnne Marie Barlier-Mur
Anne Marie Barlier-Mur
EFElie Fadel
Elie Fadel
Endothelial dysfunction is a major complication of pulmonary endarterectomy (PTE) that can lead to pulmonary edema and persistent pulmonary hypertension. We hypothesized that endothelial dysfunction is related to increased endothelial-cell (EC) death.

13 September 2011 in Critical Care
Verified
Journal Article
Open access
PDF file
CFChristophe Faisy
Christophe Faisy
FPFrancisco Pinto
Francisco Pinto
MGmorgan Le Guen
morgan Le Guen
ENEmmanuel Naline
Emmanuel Naline
SDStanislas Grassin Delyle
Stanislas Grassin Delyle
PDPhilippe Devillier
Philippe Devillier
Introduction: Lung inflation may have deleterious effects on the alveoli during mechanical ventilation. However, the consequences of stretch during excessive lung inflation on basal tone and responsiveness of human bronchi are unknown. This study was undertaken to devise an experimental model of acute mechanical stretch in isolated human bronchi and to investigate its effect on airway tone and responsiveness. Methods: Bronchi were removed from 48 thoracic surgery patients. After preparation and equilibration in an organ bath, bronchial rings were stretched for 5 min using a force (2.5 × basal tone) that corresponded to airway-inflation pressure > 30 cm H2O. The consequences of stretch were examined by using functional experiments, analysis of organ-bath fluid, and ribonucleic acid (RNA) isolation from tissue samples. Results: Following removal of the applied force the airways immediately developed an increase in basal tone (P < 0.0001 vs. paired controls) that was sustained and it did so without significantly increasing responsiveness to acetylcholine. The spontaneous tone was abolished with a Rho-kinase inhibitor and epithelium removal, a leukotriene antagonist or nitric oxide synthase inhibitors reduced it, whereas indomethacin, sensory nerve inhibitors or antagonists for muscarinic, endothelin and histamine receptors had no effect. Stretch enhanced leukotriene-E4 production during the immediate spontaneous contraction of human bronchi (P < 0.05). Moreover, stretch up-regulated the early mRNA expression of genes involved in wingless-type mouse mammary tumor virus integration-site family (WNT)-signaling and Rho-kinase pathways. Conclusions: Stretching human bronchi for only 5 min induces epithelial leukotriene release via nitric oxide synthase activation and provokes a myogenic response dependent on Rho-kinase and WNT-signaling pathways. From a clinical perspective, these findings highlight the response of human airway to acute mechanical stress during excessive pulmonary inflation.

12 January 2023 in American Journal of Transplantation
Verified
Journal Article
Open access
ARAntoine Roux
Antoine Roux
VBVincent Bunel
Vincent Bunel
NBNatalia Belousova
Natalia Belousova
JMJonathan Messika
Jonathan Messika
STSébastien Tanaka
Sébastien Tanaka
FPFrancois Parquin
Francois Parquin
Lung transplant candidates who are highly sensitized against human leucocyte antigen present an ongoing challenge with regards to finding immunologically acceptable donors. Desensitization strategies aimed at reducing preformed donor-specific antibodies have a number of limitations. Imlifidase, an IgG-degrading enzyme derived from Streptococcus pyogenes, is a novel agent that has been used to convert positive crossmatches to negative in kidney transplant candidates, allowing transplantation to occur. We present the first case of imlifidase use for antibody depletion in a highly sensitized lung transplant candidate who went on to undergo a successful bilateral lung transplant.

18 January 2019 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
JBJocelyn Bellier
Jocelyn Bellier
PLPierre Lhommet
Pierre Lhommet
PBPierre Bonnette
Pierre Bonnette
PPPhilippe Puyo
Philippe Puyo
MGMorgan Le Guen
Morgan Le Guen
TGthe Foch Lung Transplantation Group
the Foch Lung Transplantation Group

21 June 2024 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Open access
HCH. Clermidy
H. Clermidy
OMOlaf Mercier
Olaf Mercier
GBG. Brioude
G. Brioude
PMP. Mordant
P. Mordant
GFG. Fadel
G. Fadel
FTF. Tronc
F. Tronc
Pleuroparenchymal fibroelastosis (PPFE) has no currently available specific treatment. Benefits of lung transplantation (LT) for PPFE are poorly documented. We conducted a nation-wide multicentric retrospective study in patients who underwent lung or heart-lung transplantation for chronic end-stage lung disease secondary to PPFE between 2012 and 2022 in France. Thirty-one patients were included. At transplantation, median age was 48 years [IQR 35 - 55]. 64.5% were women. Twenty-one (67.7%) had idiopathic PFFE. Sixteen (52%) had bilateral LT, 10 (32%) had single LT, 4 (13%) had lobar transplantation and one (3%) had heart-lung transplantation. Operative mortality was 3.2%. Early mortality (< 90 days or during the first hospitalization) was 32%. Eleven patients (35.5%) underwent reoperation for hemostasis. Eight (30.8%) experienced bronchial complications. Mechanical ventilation time was 10 days [IQR 2-55]. Length of stay in intensive care unit and hospital were 34 [IQR 18-73] and 64 [IQR 36-103] days, respectively. Median survival was 21 months. Post-transplant survival rates after 1, 2, and 5 years were 57.9%, 42.6% and 38.3% respectively. Low albuminemia (p=0.046), FVC (p=0.021), FEV1 (p=0.009) and high emergency lung transplantation (p=0.04) were associated with increased early mortality. Oversized graft tended to be correlated to a higher mortality (p=0.07). LT for PPFE is associated with high post-operative morbi-mortality rates. Patients requiring high emergency lung transplantation with advanced disease, malnutrition, or critical clinical status experienced worse outcomes. NCT05044390.